Atazanavir 300mg / Cobicistat 150mg tablets

SNOMED code
30251911000001101
Active compound
Atazanavir + Cobicistat
Preferred name basis
Other
Prescribable
✅ Yes
Non-availability
Actual Products not Available
Non-availability date
Dose form
Discrete
Dose size and units
1 tablet, tablet
Ingredients
Cobicistat — 150 mg based on ingredient substance
Atazanavir sulfate, ID: 413592000 — 300 mg based on base substance
Form & Route
tablet.oral
Oral tablet, Oral
Controlled drug
No Controlled Drug Status

Products

Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)

Evotaz 300mg/150mg tablets

SNOMED code
30225811000001105
Supplier
Bristol-Myers Squibb Pharmaceuticals Ltd
Licensed as
Medicines - MHRA/EMA
Availability restrictions
Not available
Licensed route
Oral
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 30 tablet
30225911000001100   ref. pack		 Discontinued


Legal category: POM		5012712043492

End: 05012712043492
NHS Indicative Price
£323.38		• Hospital
  • • Prescription Charges
  • • Dispensing Fees
  • • Broken Bulk
 —

Reference packs

Atazanavir 300mg / Cobicistat 150mg tablets 30 tablet
SNOMED code
30225711000001102
Quantity and unit
30 tablet
Packs